Bill to simplify commercialization of ACT proposed

Published: 2009-10-16 06:57:00
Updated: 2009-10-16 06:57:00
A lawmaker has proposed a bill to let an autologous cell therapy commercialize with Phase I clinical trial only, holding a promise to patients with rare or life-threatening diseases.

Under the proposed bill, a drug maker who intends to market ACT will get a product license with approval of Pha...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.